NRG-GY019 - Clinical Trial
What is the Purpose of this Study?
Who Can Participate in the Study?
Adults with cancer of the ovary or peritoneum who are newly diagnosed with Stage II-IV low-grade serous ovarian cancer, fallopian tube, and primary peritoneal cancers.
What is Involved?
If you choose to join this study, you will:
- Be randomized (like flipping a coin) to Group 1 or Group 2
--Group one will take Paclitaxel and Carboplatin (standard chemotherapy drugs) folllowed by Letrozole (hormone therapy)
-- Group 2 will take only Letrozole
-Complete follow-up visits every 3 months for 3 years, and then every 6 months for 2 years